Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,058,554

« Back to Dashboard

Which drugs does patent 10,058,554 protect, and when does it expire?

Patent 10,058,554 protects PERSERIS KIT and is included in one NDA.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 10,058,554

Title:	Sustained release small molecule drug formulation
Abstract:	An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having C.sub.max to C.sub.min ratio less than 200 and lag time less than 0.2.
Inventor(s):	Luk; Andrew S. (Castro Valley, CA), Junnarkar; Gunjan H. (Palo Alto, CA), Chen; Guohua (Sunnyvale, CA)
Assignee:	Indivior UK Limited (Slough, Berkshire, GB)
Application Number:	15/422,626
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 10,058,554
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,058,554

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Indivior Inc	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-001	Jul 27, 2018		RX	Yes	No	➤ Sign Up	➤ Sign Up				ADMINISTRATION OF RISPERIDONE	➤ Sign Up
Indivior Inc	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-002	Jul 27, 2018		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				ADMINISTRATION OF RISPERIDONE	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 10,058,554

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	056554	➤ Sign Up
Austria	551989	➤ Sign Up
Australia	2006299657	➤ Sign Up
Canada	2624088	➤ Sign Up
China	101365423	➤ Sign Up
Denmark	1940351	➤ Sign Up
Denmark	2361609	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.